期刊文献+

胃癌发生过程中端粒酶活性测定及临床意义

Telomerase activity and its clinical significance in progression of gastric carcinoma
在线阅读 下载PDF
导出
摘要 目的:通过检测胃癌及癌前病 变组织中端粒酶活性,探讨其在胃癌发 生发展中的作用及临床意义。方法:采 用SP免疫组化法检测40例胃癌和18 例癌前病变(其中慢性萎缩性胃炎伴肠 化生10例,非典型增生8例)端粒酶活 性。结果:胃癌及癌前病变中端粒酶阳 性率分别为92.5%(37/40)和33.3% (6/18),两者比较差异有统计学意义, P<0.05。端粒酶激活与胃癌的分化 程度、病理分期和淋巴结转移无明显相 关性,P>0.05。结论:端粒酶活性表 达与胃癌的发生密切相关,利用免疫组 化检测端粒酶活性可作为胃癌早期诊 断的参考指标,并应对阳性病例进行跟 踪随访。 OBJECTIVE: To explore the clinical significance of telomerase expression in the progression of gastric carcinoma through detection telomerase activity in gastric carcinoma and precancerous lesions. METHODS: Telomerase activity was determined by using the SP immunohistochemical technique in 40 cases of gastric cancer and 18 cases of gastric precancerous lesions (10 cases of chronic atrophic gastritis with intestinal metaplasia, 8 cases of dysplasia). RESULTS: The positive rates of telomerase in gastric cancer and gastric precarcinoma were 92.5%(37/40) and 33.3%(6/18) respectively. There was a significant difference between the two groups, P〈0.05. There was no obvious correlation between telomeras activity and differentiation, pathological stage, lymph node metastasis of gastric carcinoma,P〉0.05. CONCLUSIONS: There may be a close relationship between telomerase activity expression and progression of gastric cancer. Detecting telomerase activity may serve as a reference index of gastric carcinoma early diagnosis by the SP immunohistochemistry, and the positive cases should be followed up.
出处 《肿瘤防治杂志》 2005年第4期283-285,共3页 China Journal of Cancer Prevention and Treatment
关键词 胃肿瘤 癌前状态 端粒 免疫组织化学 gastric neoplasms precancerlous conditions telomerase immunohistochemistry
作者简介 冯艳玲,女,河南濮阳人,硕士,副教授,主要从事消化道肿瘤研究的工作。Tel:86-373-3029347;E-mail:FYL-HY@163.com。
  • 相关文献

参考文献8

  • 1杨仕明,房殿春,罗元辉,鲁荣,刘为纹.胃癌及癌前组织中端粒酶活性的检测及其临床意义[J].中华医学杂志,1998,78(3):207-209. 被引量:52
  • 2Soria J C, Rixe O. Telomeres, telomerase and cancer[J]. Bull Cancer, 1977,84(10) :963-970.
  • 3Kim N W, Pieatyszek M A, Prowse K R, et al. Specific association of human telomerase activity with immortal cells and cancer[J]. Science,1994,266(5232) :2011.
  • 4Shay J W, Wright W E. The reactivation of telomerase activity in cancer progression [J]. Trends Genet, 1996,12 (1) : 129.
  • 5Altshuler M L, Severin S E, Glukhov A L, et al. The tumor cell and telomerase[J]. Biochemistry, 2003, 68 (12) : 1275 -1283.
  • 6Gollahon L S, Shay J W. Immortalization of human mammary endothelial cells transfected with mutant p53 (273 his ) [J].Oncogene,1996,12(4) :715-725.
  • 7Wang J, Xie L Y, Allan S, et al. Myc activates telomerase [J].Genes Dev, 1998,12 (12) : 1769- 1774.
  • 8Ahn M J, Noh Y H, Lee Y S, et al. Telomerase activity and its clinicopathological significance in gastric cancer [J]. Eur J Cancer, 1997,33(8) :1307-1312.

二级参考文献2

  • 1杨仕明,中华消化内镜杂志,1997年,19卷,401页
  • 2Feng J L,Science,1995年,269卷,1326页

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部